For the three cancers, SNVs were more likely to be detected in the high-OGT expression group than in the low-OTG expression group, and the top five genes with the highest frequency of SNV were MUC17, PIK3CA, SI, SYNE1, and PTEN (Figure S3). This evidence concerns the gene OGT and cancer.